Skip to main content
Autobound logo

AbbVie news and events in 2026

AbbVie is a biopharmaceutical organization that discovers and develops medicines and healthcare solutions. The organization focuses its research and production on therapeutic areas including immunology, oncology, neuroscience, eye care, and aesthetics.

Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn

Dated updates
94
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
383
Latest SEC filing
Sep 3, 2026

Overview

AbbVie by topic

Latest events

Latest AbbVie events

All AbbVie news →
  1. Partnership
    AbbVie Teams Up With Valkai to Use AI in Clinical DevelopmentAbbVie has partnered with life sciences AI platform Valkai to deploy artificial intelligence technology to improve efficiency in clinical research and reduce development timelines.
    finance.yahoo.com
  2. Integration
    Valkai partners with AbbVie to apply advanced AI in targeted areas of clinical developmentAbbVie will deploy AI capabilities from Valkai to improve efficiency in targeted areas of clinical research.
    ch.zonebourse.com
  3. Launch
    U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's DiseaseAbbVie's Parkinson's disease treatment, JUVMO™ (tavapadon), has been approved by the U.S. Food and Drug Administration (FDA) and is expected to be available to patients in the U.S. in October 2026.
    prnewswire.com
  4. Launch
    AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic ArthritisAbbVie's drug RINVOQ (upadacitinib) received approval from the European Commission for treating active polyarticular juvenile idiopathic arthritis in patients aged two and older.
    prnewswire.com
  5. Partnership
    AbbVie partners with Iambic in AIAbbVie has entered into a multi-year partnership with Iambic to accelerate the discovery and development of innovative drug molecules in immunology, neurobiology, and oncology.
    ch.marketscreener.com
  6. Investment
    Drug developer ADARx seeks $1.74 billion valuation in US IPO$100M · With ADARx Pharmaceuticals · 2 stories
    sg.finance.yahoo.com
  7. In development
    AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) MeetingAbbVie is developing ABBV-2001 (ISB 2001), a CD38 x BCMA x CD3 trispecific T-cell engager, as part of its multiple myeloma pipeline.
    prnewswire.com
  8. Partnership
    AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health CampaignAbbVie and the PGA TOUR announced a partnership naming AbbVie the Official Pharmaceutical Sponsor of the PGA TOUR and the 2026 Presidents Cup.
    prnewswire.com
  9. In development
    AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual MigraineAbbVie announced positive topline results from its Phase 3 LUNA study for atogepant, a preventive treatment for menstrual migraine in adults, which met its primary endpoint and all eight ranked secondary endpoints.
    prnewswire.com
  10. Earnings
    AbbVie Inc. stock gains on Apogee deal and reaffirmed 2026 guidanceAbbVie reaffirmed its adjusted EPS guidance for fiscal year 2026 at USD 13.87 to USD 14.07.
    ad-hoc-news.de

Showing 10 of 34 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track AbbVie with the Signal API

One POST /v1/companies/enrich call with abbvie.com returns every signal type for AbbVie, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbvie.com","limit":20}'

Same industry

Companies related to AbbVie

AbbVie questions

What is the latest news on AbbVie?
On Sep 29, 2026, finance.yahoo.com reported: AbbVie Teams Up With Valkai to Use AI in Clinical Development. This page tracks 34 news events for AbbVie since Apr 22, 2026, each with a date and a source link.
What is going on with AbbVie?
In the 90 days to Sep 30, 2026, Autobound tracked 19 news events, 1 10-Q filing, 4 8-K filings, 4 hiring snapshots, 1 deal, 33 signals for AbbVie. The newest story is from Sep 29, 2026 (Partnership), reported by finance.yahoo.com.
Has AbbVie announced any acquisitions?
The latest deal story is from Aug 29, 2026. ad-hoc-news.de reported: Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progress. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for AbbVie?
Beyond news and filings, Autobound lists 49+ signals for AbbVie from 6 sources: X (Twitter) (15+), Glassdoor (14), LinkedIn (14), Patents (3), Reddit (2), Podcasts (1). See the AbbVie signals page for the dated list.
Is AbbVie hiring right now?
Yes. As of Sep 29, 2026, AbbVie had 383 open roles, and Research and development had the most with 28.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →